FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978077680> ?p ?o ?g. }

• W1978077680 endingPage "1934" @default.
• W1978077680 startingPage "1929" @default.
• W1978077680 abstract "Background/Aims Erythropoietin (EPO) has been widely used for the treatment of anemia in chronic kidney disease (CKD). A growing body of evidence indicates that the therapeutic benefits of EPO could extend beyond the improvement of anemia. The aim of the present study was to determine whether EPO affects renovascular and oxidative stress biomarkers in pre-dialysis CKD patients with anemia. Methods The study was a single-arm prospective study. Fifteen CKD patients (9 males and 6 females, mean age 63 years) with anemia (mean Hb: 8.1 g/dL) were treated with recombinant human EPO; 12,000 U administered subcutaneously once every 2 weeks. Various parameters were measured before and 6 months after treatment. These included serum hemoglobin (Hb), creatinine, estimated glomerular filtration rate (eGFR), proteinuria, urinary liver-type fatty acid binding protein (L-FABP - a biomarker of renal injury), urinary 8-hydroxydeoxyguanosine (8-OHdG - a marker of oxidative stress), serum asymmetrical dimethylarginine (ADMA), carotid artery intima-media thickness (IMT) and brachial-ankle pulse wave velocity (baPWV) as vascular markers and plasma brain natriuretic peptide (BNP) levels and left ventricular ejection fraction (LVEF) as cardiac function markers and cardio-thoracic ratio (CTR) and inferior vena cava dimension (IVCS) as extra fluid retention markers. Results After 6 months, serum Hb was significantly increased (p<0.001) and urinary levels of protein, L-FABP and 8-OHdG, carotid IMT, baPWV, plasma BNP and serum ADMA levels were significantly decreased (p<0.001). Serum creatinine, eGFR, LVEF, CTR and IVCS showed little difference throughout the experimental period. Conclusion These data suggest that recombinant human EPO may ameliorate renal injury, oxidative stress and progression of atherosclerosis in addition to improving anemia in CKD patients." @default.
• W1978077680 created "2016-06-24" @default.
• W1978077680 creator A5009354339 @default.
• W1978077680 creator A5018174072 @default.
• W1978077680 creator A5021468317 @default.
• W1978077680 creator A5039403849 @default.
• W1978077680 creator A5052966356 @default.
• W1978077680 creator A5070411311 @default.
• W1978077680 creator A5079491668 @default.
• W1978077680 date "2011-01-01" @default.
• W1978077680 modified "2023-10-03" @default.
• W1978077680 title "Renovascular Protective Effects of Erythropoietin in Patients with Chronic Kidney Disease" @default.
• W1978077680 cites W1509535546 @default.
• W1978077680 cites W1710698527 @default.
• W1978077680 cites W1972128848 @default.
• W1978077680 cites W1974025920 @default.
• W1978077680 cites W1976845718 @default.
• W1978077680 cites W1977312076 @default.
• W1978077680 cites W1979332976 @default.
• W1978077680 cites W1990042945 @default.
• W1978077680 cites W2000183862 @default.
• W1978077680 cites W2001564631 @default.
• W1978077680 cites W2028295746 @default.
• W1978077680 cites W2028305978 @default.
• W1978077680 cites W2032270024 @default.
• W1978077680 cites W2033824282 @default.
• W1978077680 cites W2037689330 @default.
• W1978077680 cites W2048246006 @default.
• W1978077680 cites W2048578614 @default.
• W1978077680 cites W2053043470 @default.
• W1978077680 cites W2068087869 @default.
• W1978077680 cites W2071328905 @default.
• W1978077680 cites W2087554021 @default.
• W1978077680 cites W2093655079 @default.
• W1978077680 cites W2094315552 @default.
• W1978077680 cites W2094556340 @default.
• W1978077680 cites W2117156673 @default.
• W1978077680 cites W2123758810 @default.
• W1978077680 cites W2135422127 @default.
• W1978077680 cites W2144931343 @default.
• W1978077680 cites W2149572201 @default.
• W1978077680 cites W2153231314 @default.
• W1978077680 cites W2156679097 @default.
• W1978077680 cites W2168294078 @default.
• W1978077680 doi "https://doi.org/10.2169/internalmedicine.50.5145" @default.
• W1978077680 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21921371" @default.
• W1978077680 hasPublicationYear "2011" @default.
• W1978077680 type Work @default.
• W1978077680 sameAs 1978077680 @default.
• W1978077680 citedByCount "15" @default.
• W1978077680 countsByYear W19780776802012 @default.
• W1978077680 countsByYear W19780776802013 @default.
• W1978077680 countsByYear W19780776802014 @default.
• W1978077680 countsByYear W19780776802015 @default.
• W1978077680 countsByYear W19780776802016 @default.
• W1978077680 countsByYear W19780776802018 @default.
• W1978077680 countsByYear W19780776802020 @default.
• W1978077680 countsByYear W19780776802023 @default.
• W1978077680 crossrefType "journal-article" @default.
• W1978077680 hasAuthorship W1978077680A5009354339 @default.
• W1978077680 hasAuthorship W1978077680A5018174072 @default.
• W1978077680 hasAuthorship W1978077680A5021468317 @default.
• W1978077680 hasAuthorship W1978077680A5039403849 @default.
• W1978077680 hasAuthorship W1978077680A5052966356 @default.
• W1978077680 hasAuthorship W1978077680A5070411311 @default.
• W1978077680 hasAuthorship W1978077680A5079491668 @default.
• W1978077680 hasBestOaLocation W19780776801 @default.
• W1978077680 hasConcept C126322002 @default.
• W1978077680 hasConcept C126894567 @default.
• W1978077680 hasConcept C134018914 @default.
• W1978077680 hasConcept C159641895 @default.
• W1978077680 hasConcept C164705383 @default.
• W1978077680 hasConcept C185592680 @default.
• W1978077680 hasConcept C2778198053 @default.
• W1978077680 hasConcept C2778248108 @default.
• W1978077680 hasConcept C2778319312 @default.
• W1978077680 hasConcept C2778534260 @default.
• W1978077680 hasConcept C2778653478 @default.
• W1978077680 hasConcept C2780306776 @default.
• W1978077680 hasConcept C2781197716 @default.
• W1978077680 hasConcept C55493867 @default.
• W1978077680 hasConcept C71924100 @default.
• W1978077680 hasConcept C78085059 @default.
• W1978077680 hasConcept C84393581 @default.
• W1978077680 hasConcept C90924648 @default.
• W1978077680 hasConceptScore W1978077680C126322002 @default.
• W1978077680 hasConceptScore W1978077680C126894567 @default.
• W1978077680 hasConceptScore W1978077680C134018914 @default.
• W1978077680 hasConceptScore W1978077680C159641895 @default.
• W1978077680 hasConceptScore W1978077680C164705383 @default.
• W1978077680 hasConceptScore W1978077680C185592680 @default.
• W1978077680 hasConceptScore W1978077680C2778198053 @default.
• W1978077680 hasConceptScore W1978077680C2778248108 @default.
• W1978077680 hasConceptScore W1978077680C2778319312 @default.
• W1978077680 hasConceptScore W1978077680C2778534260 @default.
• W1978077680 hasConceptScore W1978077680C2778653478 @default.
• W1978077680 hasConceptScore W1978077680C2780306776 @default.
• W1978077680 hasConceptScore W1978077680C2781197716 @default.

• next